BEAM vs IFF · rev $63.5M vs P/E 24, rev $11.48B
Beam Therapeutics Inc (BEAM) versus International Flavors & Fragrances Inc (IFF) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
International Flavors & Fragrances Inc (IFF) is a specialty chemicals company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported IFF revenue for 2024-12-31 was $11.48B. Net income was $247.0M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
BEAM currently screens at market cap $2.01B. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
Not investment advice. Open the BEAM and IFF stock pages for the full models.
Not investment advice.